Healixa Inc.
EMOR · OTC
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $7,160 | $39,482 | $61,332 | $25,143 |
| - Cash | $86 | $27 | $86 | $64 |
| + Debt | $6,591 | $7,040 | $6,591 | $6,547 |
| Enterprise Value | $13,666 | $46,495 | $67,837 | $31,626 |
| Revenue | $389 | $92 | $389 | $128 |
| % Growth | 323.6% | -76.4% | 204.1% | – |
| Gross Profit | $268 | $12 | $268 | $9 |
| % Margin | 69% | 12.6% | 69% | 6.8% |
| EBITDA | $38 | -$142 | $30 | -$170 |
| % Margin | 9.7% | -154.3% | 7.6% | -133% |
| Net Income | -$51 | -$142 | -$51 | -$212 |
| % Margin | -13.2% | -154.3% | -13.2% | -165.5% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 50% | -100% | 66.7% | – |
| Operating Cash Flow | -$152 | – | -$69 | -$83 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | -$152 | – | -$69 | -$83 |